December 13th 2024
Unloxcyt was approved by the FDA as a new treatment for patients with locally advanced or metastatic cutaneous squamous cell carcinoma.
December 13th 2024
December 13th 2024
December 12th 2024
December 11th 2024
December 10th 2024
December 6th 2024
December 5th 2024
December 1st 2024
November 24th 2024
November 30th 2024
November 27th 2024
November 23rd 2024
November 16th 2024